Costs of Eating Disorders Quantified for the United States
WEDNESDAY, March 3, 2021 -- The impact of eating disorders in the United States was close to $400 billion for fiscal year 2018 to 2019 when considering both economic costs and reduced well-being, according to a study published online March 3 in the International Journal of Eating Disorders.
Jared Streatfeild, from Deloitte Access Economics in Canberra, Australia, and colleagues estimated costs of eating disorders using a bottom-up cost-of-illness methodology based on the estimated one-year prevalence of eating disorders. Using disability-adjusted life years, intangible costs of reduced well-being were also estimated.
The researchers estimated total economic costs associated with eating disorders to be $64.7 billion in fiscal year 2018 to 2019, which was equivalent to $11,808 per affected individual. Thirty-five percent of the total costs were accounted for by "otherwise specified feeding or eating disorder," followed by 30, 18, and 17 percent for binge eating disorder, bulimia nervosa, and anorexia nervosa, respectively. The eating disorder-associated reduction in well-being was estimated at $326.5 billion.
"Our study lays bare the devastating economic impact that eating disorders have in the United States, a country where the majority of people affected suffer alone and never receive appropriate treatment because of barriers to health care and lack of training for health care providers," a coauthor said in a statement.
© 2021 HealthDay. All rights reserved.
Posted: March 2021
Read this next
THURSDAY, April 8, 2021 -- For children with B-cell acute lymphoblastic leukemia (B-ALL), a diet and exercise intervention might improve disease response, according to a study...
MONDAY, April 5, 2021 -- From 2005 to 2015, there was an increase in prolonged length of stay (LOS) for pediatric mental health emergency department visits, according to a study...
THURSDAY, April 1, 2021 -- Once-weekly subcutaneous semaglutide results in significantly greater weight loss than placebo when used as adjunctive therapy over 68 weeks in adults...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.